Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2009-03-27
2011-11-22
Minnifield, Nita M (Department: 1645)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
Reexamination Certificate
active
08063193
ABSTRACT:
The present invention is directed to novel polynucleotides and polypeptides directed to EXP1 ofPlasmodium vivax, and methods of using these polynucleotides and polypeptides in the detection ofP. vivaxantibodies or anti-P. vivaxantibodies in a subject. The invention finds particular useful application in identifying recent exposure toP. vivax.
REFERENCES:
patent: 4582788 (1986-04-01), Erlich
patent: 4683194 (1987-07-01), Saiki et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4948882 (1990-08-01), Ruth
patent: 5006309 (1991-04-01), Khalil et al.
patent: 5063081 (1991-11-01), Cozzette et al.
patent: 5089424 (1992-02-01), Khalil et al.
patent: 5107065 (1992-04-01), Shewmaker et al.
patent: 5231020 (1993-07-01), Jorgensen et al.
patent: 5424414 (1995-06-01), Mattingly
patent: 5464746 (1995-11-01), Fino
patent: 5700671 (1997-12-01), Prieto et al.
patent: 5705330 (1998-01-01), Shah et al.
patent: 5750176 (1998-05-01), Prieto et al.
patent: 6395472 (2002-05-01), Leary et al.
patent: 2003/0170881 (2003-09-01), Davis et al.
patent: 2004/0018577 (2004-01-01), Emerson Campbell et al.
patent: 2005/0054078 (2005-03-01), Miller et al.
patent: 2006/0160164 (2006-07-01), Miller et al.
patent: 5042 (1985-09-01), None
patent: 84796 (1990-05-01), None
patent: 237362 (1992-03-01), None
patent: 201184 (1992-12-01), None
patent: 258017 (1997-06-01), None
patent: WO9220702 (2006-07-01), None
Invitrogen (Product Catalog, 1997).
EMBL (EMBL-Bank, accession No. AAKM01000005.1, available Sep. 22, 2005, annotated in Jun. 2007).
Ausubel F. M., et al., “Current Protocols in Molecular Biology,” 1987, John Wiley & Sons.
Boerner P. R. et al., “Production of antigen-specific human monoclonal antibodies from in vitro-primed human splenocytes,” J Immunol, 1991, vol. 147, pp. 86-95.
Brennan M. et al., “Preparation of bispecific antibodies by chemical recombination of monoclonal immunoglobulin G1 fragments,” Science, 1985, vol. 229, pp. 81-83.
Calton Jane M., et al., “Comparative genomics of the neglected human malaria parasitePlasmodium vivax”, Nature, 2008, 455,757-763.
Carter P., “Site-directed mutagenesis,” Biochem J., 1986, vol. 237, pp. 1-7.
Charoenvit et al. , “CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from aPlasmodium yoelii17-kilodalton hepatocyte erythrocyte protein,” Infect Immun, 1999, vol. 67 (11), pp. 5604-5614.
Circumsporozoite-protein related antigen, XP002583503, 2009.
Doderer C. et al., “A new ELISA kit which uses a combination ofPlasmodium falciparumextract and recombinantPlasmodium vivaxantigens as an alternative to IFAT for detection of malaria antibodies,” Malar J, 2007, vol. 6, pp. 19.
Doolan DL., et al., “Identification and Characterization of the Protective Hepatocyte Erythrocyte Protein 17 kDa Gene ofPlasmodium yoelii, homolog ofPlasmodium falciparumExported Protein”, Journal of Biological Chemistry, 1996, 271 (30), 757-763.
Elghouzzi M. H. et al. , “Multicentric evaluation of the DiaMed enzyme-linked immunosorbent assay malaria antibody test for screening of blood donors for malaria,” Vox Sang, 2008, vol. 94, pp. 33-40.
Fishwild D. M. et al., “High-avidity human IgG kappa monoclonal antibodies from a novel strain of minilocus transgenic mice,” Nat Biotechnol, 1996, vol. 14, pp. 845-851.
Galfre G. et al., “Antibodies to major histocompatibility antigens produced by hybrid cell lines,” Nature, 1977, vol. 266, pp. 550-552.
Girard MP et al. , “A review of human vaccine research and development: Malaria,” Vaccine, 2007, vol. 25, pp. 1567-1580.
Goding J. W., “Monoclonal antibodies: Principles and Practice”, 1996, Academic Press, pp. 492.
Harlow E., et al., “Antibodies: A Laboratory Manual,” Table of Contents, 1988, Cold Spring Harbor Laboratory Press.
Holliger P., et al., “”Diabodies“: Small bivalent and Bispecific Antibody Fragments,” PNAS USA, 1993, 90, 6444-6448.
Hoogenboom H. R., et al., Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains, Nucleic Acids Research, 1991, 19 (15), Oxford University Press, 4133-4137.
Hope I. A. et al. , “Evidence for immunological cross-reaction between sporozoites and blood stages of a human malaria parasite,” Nature, 1984, vol. 308, pp. 191-194.
Ingelbrecht et al., “Different 3[prime] End Regions Strongly Influence the Level of Gene Expression in Plant Cells” Plant Cell , 1989, vol. 1, pp. 671-680.
Jones J. D. et al. , “High level expression of introduced chimaeric genes in regenerated transformed plants,” Embo J, 1985, vol. 4, pp. 2411-2418.
Jones P. T., et al, “Replacing the complementarity-determining regions in a human antibody with those from a mouse,” Nature, 1986, 321, 522-525.
Kara U. et al. , “Chemical characterization of the parasitophorous vacuole membrane antigen QF 116 fromPlasmodium falciparum,” Mol Biochem Parasitol, 1990, vol. 38, pp. 19-23.
Kaufman R. J., “Vectors used for expression in mammalian cells,” Methods Enzymol, 1990, vol. 185, pp. 487-511.
Kim S. et al. , “ELISA detection of vivax malaria with recombinant multiple stage-specific antigens and its application to survey of residents in endemic areas,” Korean J Parasitol, 2003, vol. 41, pp. 203-207.
Kim Sera, et al., “ELISA-based detection of vivax malaria using recombinant 6xHis-tagged antigens”, 2005.
Kitchen A. D. et al. , “Evaluation of a malarial antibody assay for use in the screening of blood and tissue products for clinical use ,” Vox Sang, 2004, vol. 87, pp. 150-155.
Kostelny S. A. et al., “ Formation of a bispecific antibody by the use of leucine zippers,” J Immunol, 1992, vol. 148, pp. 1547-1553.
Lee J. S. et al. , “Current status of vivax malaria among civilians in Korea,” Korean J Parasitol, 1998, vol. 36, pp. 241-248.
Lonberg N., et al., “Human Antibodies from Transgenic Mice,” Intern Rev Immunol, 1995, 13, 65-93.
Longberg N. et al. , “Antigen-specific human antibodies from mice comprising four distinct genetic modifications ,” Nature, 1994, vol. 368, pp. 856-859.
Luckow V. A. , “Cloning and expression of heterologous genes in insect cells with baculovirus vectors In Recombinant DNA technology and applications,” 1991, A. Prokop, R.K. Bajpai, and C. Ho, editors. McGraw-Hill, pp. 97-152.
Marks J. D. et al. , “By-passing immunization: building high affinity human antibodies by chain shuffling,” Biotechnology , 1992, vol. 10, pp. 779-783.
Marks J. D. et al., “By-passing immunization. Human antibodies from V-gene libraries displayed on phage,” J Mol Biol, 1991, vol. 222, pp. 581-597.
Meraldi V. et al. , “Recognition of synthetic polypeptides corresponding to the N- and C-terminal fragments ofPlasmodium falciparumExp-1 by T-cells and plasma from human donors from African endemic areas,” Parasite Immunol, 2002, vol. 24, pp. 141-150.
Meraldi V., et al., “Natural antibody response toPlasmodium falciparumExp-1, MSP-3 and GLURP long synthetic peptides and association with protection”, Parasite Immunol, 2004, 26(6-7), 7861-17668.
Mertens G. et al. , “Malaria antibody ELISA insufficiently sensitive for blood donor screening,” Vox Sang, 1999, vol. 77, pp. 237-238.
Milstein C. et al, “Hybrid hybridomas and their use in immunohistochemistry,” Nature, 1983, vol. 305, pp. 537-540.
Morrison S. L. et al. , “Genetically engineered antibody molecules and their application,” Ann N Y Acad Sci, 1987, vol. 507, pp. 187-198.
Mullis K. et al., “Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction,” Cold Spring Harb Symp Quant Biol, 1986, vol. 51 (Pt 1), pp. 263-273.
Mungai M. et al. , &#
Birkenmeyer Larry G.
Coffey Ruthie E.
Dawson George J.
Desai Suresh M.
Dille Bruce J.
Abbott Laboratories
Becker Cheryl L.
Gangle Brian J
Minnifield Nita M
LandOfFree
Nucleotide and amino acid sequences encoding an exported... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleotide and amino acid sequences encoding an exported..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleotide and amino acid sequences encoding an exported... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4308045